Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

収録刊行物

  • The Lancet

    The Lancet 391 (10125), 1076-1084, 2018-03

    Elsevier BV

被引用文献 (5)*注記

もっと見る

問題の指摘

ページトップへ